NERVGEN PHARMA CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 CAD | +7.87% |
|
+10.43% | -13.70% |
| Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
| Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar NervGen Pharma Corp.
663b9c6aee561d5887d5.857nhEVGsK9dVPcWOBW4u9hvEp9QxomelPGPZHwvIho.vPK98QMD3pZlHoFhdGX796AMVvcfqL-prcTfHRd2dS6E7rPzCgn8_BcCsg~ddd0573f1e43931bb56533bede22a9bd
Upcoming events on NervGen Pharma Corp.
Past events on NervGen Pharma Corp.
| 2024-04-17 08:32 am | Q4 2023 Earnings Release |
| 2023-11-09 08:30 am | Q3 2023 Earnings Release |
| 2023-09-14 10:10 am | International Spinal Research Trust Network Meeting |
| 2023-09-13 04:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-11 | Investor Meeting |
| 2023-08-24 11:00 am | Investor Meeting - Key Opinion Leader |
| 2023-08-09 08:30 am | Q2 2023 Earnings Release |
| 2023-06-22 11:30 am | OTC Life Science Investor Forum |
| 2023-05-17 04:00 pm | Annual General Meeting |
| 2023-05-15 08:01 am | Q1 2023 Earnings Release |
| 2023-04-16 | American Spinal Injury Association Scientific Meeting |
| 2023-03-30 08:30 am | Q4 2022 Earnings Release |
| 2022-11-14 08:03 am | Q3 2022 Earnings Release |
| 2022-10-25 | European Committee for Treatment and Research in Multiple Sclerosis Congress |
| 2022-10-21 | American Neurological Association Meeting |
| 2022-09-28 01:00 pm | Annual General Meeting |
| 2022-09-16 | International Spinal Cord Society Scientific Meeting |
| 2022-09-11 | Military Health System Research Symposium |
| 2022-08-10 08:03 am | Interim 2022 Earnings Release |
| 2022-05-19 07:20 am | International Investment Forum |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | -8,75 -9,90 11.59% | -20,1 -19,0 -5.97% | -11,6 | -21,6 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | -12,8 -11,6 -10.92% | -23,0 -24,7 6.78% | 0,00 | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million CAD | Released Forecast Spread | -11,2 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EPS CAD | Released Forecast Spread | -0,35 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
| Announcement Date | 08/04/21 | 28/02/22 | 30/03/23 | 17/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |||||
|
EBITDA Million CAD | Released Forecast Spread | -3,06 -2,40 -27.46% | -4,20 -2,60 -61.38% | -5,45 -4,00 -36.19% | -4,28 -5,70 24.92% | -6,21 -5,10 -21.81% | -4,50 | -6,20 | -5,60 | -5,30 |
|
EBIT Million CAD | Released Forecast Spread | -4,15 -3,50 -18.47% | -5,00 -3,60 -39.01% | -6,31 -5,00 -26.26% | -4,92 -6,80 27.59% | -6,78 -6,20 -9.42% | ||||
| Announcement Date | 28/02/22 | 12/05/22 | 10/08/22 | 14/11/22 | 30/03/23 | - | - | - | - |
| 2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 01:00 am | VALNEVA: Q1 2024 Earnings Release |
| 2024-05-07 07:00 am | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for NervGen Pharma Corp.
| 2024-05-02 04:10 pm | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 am | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NGEN Stock
- Calendar NervGen Pharma Corp.
